Researchers North Carolina State University, the University of North Carolina-Chapel Hill, and Duke University School of Medicine have developed a new tool for addressing disseminated intravascular coagulation, a blood disorder that proves fatal in many patients. The researchers developed a technique that makes use of nanogel spheres, which are loaded with tissue-type plasminogen activator – a drug that breaks down blood clots. The spheres travel through the bloodstream until they reach a blood clot, at which point they stick to fibrin, the main protein found in blood clots.
An official website of the United States government.